Possible alternate approaches to increase sensitivity of detection of residual disease in MDS could be achieved by performing FISH or SNP-CMA on lineage specific CD34+ (or alternatively, CD117+) enriched cells from peripheral blood or bone marrow after magnetic cell separation or flow cytometric sorting [90,91]. This evidence concerns the gene CD34 and myelodysplastic syndrome.